Yen plans to use a well-tolerated bio-agent to fundamentally improve the hospitability to T cells in brain tumors to enable effective immunotherapy
- About
- Education
- Research
- Research Departments
- Research Offices
- Research Centers
- Cancer Center
- Cancer Research
- Cardiovascular Research Center
- Carter Immunology Center
- Center for Behavioral Health & Technology
- Center for Brain Immunology & Glia
- Center for Diabetes Technology
- Center for Immunity, Inflammation & Regenerative Medicine
- Center for Public Health Genomics
- Center for Membrane & Cell Physiology
- Center for Research in Reproduction
- Myles H. Thaler Center for AIDS & Human Retrovirus Research
- Child Health Research Center (Pediatrics)
- Division of Perceptual Studies
- Research News: The Making of Medicine
- Research Core Facilities
- Other Research Programs
- Policies & Guidelines
- Clinical
- Community
- Diversity
- News